The importance of a transcriptional crosstalk between ZEB1‐RUNX2 and Smad in breast cancer progression and EMT remains to be analyzed; such crosstalk most probably links to the mesenchymal program induced by these three transcriptional regulators. Here, RUNX2 is linked to breast cancer.